STAAR Surgical(US:STAA) ZACKS·2025-05-08 00:05Core Insights - Staar Surgical reported a revenue of $42.59 million for the quarter ended March 2025, which is a 45% decrease compared to the same period last year [1] - The earnings per share (EPS) for the quarter was -$0.52, a decline from $0.06 in the year-ago quarter, but it exceeded the consensus EPS estimate of -$0.59 by 11.86% [1] - The revenue surpassed the Zacks Consensus Estimate of $40.34 million by 5.57% [1] Financial Performance - The stock of Staar Surgical has returned +23.5% over the past month, outperforming the Zacks S&P 500 composite's +10.6% change [3] - The company currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3] Geographic Sales Breakdown - In the United States, net geographic sales were $5.46 million, slightly below the average estimate of $5.82 million, representing a year-over-year increase of +10.6% [4] - In Japan, net geographic sales reached $11.39 million, exceeding the average estimate of $10.54 million, with a year-over-year change of +8.9% [4] - In China, net geographic sales were only $0.39 million, significantly lower than the estimated $1.15 million, marking a drastic year-over-year decline of -99% [4]